Neil Guha

Contact

• workRoom Nottingham Digestive Diseases Centre BRU, Level E, West Block QMC
  Queen's Medical Centre
  Nottingham
  NG7 2UH
  UK
• work0115 924 9924
• fax0115 970 9955
• neil.guha@nottingham.ac.uk

Expertise Summary

Neil Guha is a Professor of Hepatology at the University of Nottingham. He trained at Guy's and St. Thomas's hospitals and began his postgraduate career in hepatology at St. Mary's Hospital, London. His doctoral thesis, awarded by the University of Southampton, focussed on non-invasive biomarkers of liver fibrosis. He completed his clinical training at the Southampton Liver Unit and was appointed as a clinical lecturer by the University of Southampton in 2008. He moved to Nottingham in 2009 to commence his current post at the National Institute of Health Research Nottingham Biomedical Research Unit/Centre. His research continues to focus on biomarkers of liver fibrosis with current work in serum markers, hypothesis generating technologies, imaging modalities and utilisation of biomarkers in clinical practice including innovative pathways of care. He was a previous NHS Innovation Accelerator Fellow (2015-2018) and is currently (2019 - present) an Associate Senior Tutor at the Centre for Evidence-Based Medicine, University of Oxford. He is the deputy theme lead for GI/Liver within the NIHR Nottingham Biomedical Research Centre.

Research Summary

Non-invasive assessment of liver fibrosis Experimental diagnostics of chronic liver injury Clinical application of liver biomarkers Novel MRI imaging techniques in chronic liver… read more

Selected Publications

• GUHA, I.N., PARKES, J., RODERICK, P., CHATTOPADHYAY, D., CROSS, R., HARRIS, S., KAYE, P., BURT, A.D., RYDER, S.D., AITHAL, G.P., DAY, C.P. and ROSENBERG, W.M., 2008. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers Hepatology: Official Journal of the American Association of the Study of Liver Diseases. 47(2), 455-460
• TANWAR, S., TREMBLING, P.M., GUHA, I.N., PARKES, J., KAYE, P., BURT, A.D., RYDER, S.D., AITHAL, G.P., DAY, C.P. and ROSENBERG, W.M., 2013. Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease Hepatology. 57(1), 103-111
• HARMAN DJ, RYDER SD, JAMES MW, JELPKE M, OTTEY DS, WILKES EA, CARD TR, AITHAL GP and GUHA IN, 2015. Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography. BMJ open. 5(4), e007516
• PRITCHETT, J., HARVEY, E., ATHWAL, V., BERRY, A., ROWE, C., OAKLEY, F., MOLES, A., MANN, D.A., BOBOLA, N., SHARROCKS, A.D., THOMSON, B.J., ZAITOUN, A.M., IRVING. W.L., GUHA, I.N., HANLEY, N.A. and HANLEY, K.P., 2012. Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans Hepatology. 56(3), 1108-1116

• View all publications

Current Research

• Non-invasive assessment of liver fibrosis
• Experimental diagnostics of chronic liver injury
• Clinical application of liver biomarkers
• Novel MRI imaging techniques in chronic liver injury
• Stratification of liver disease in the community

• CHALMERS, JANE, WILKES, EMILIE, HARRIS, REBECCA, KENT, LUCY, KINRA, SONALI, AITHAL, GURU, HOLMES, MARY, JOHNSON, JEANETTE, MORLING, JOANNE and GUHA, INDRA NEIL, 2020. Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community FRONTLINE GASTROENTEROLOGY. 11(2), 86-92
• FATEEN, WALEED, RAGUNATH, KRISH, WHITE, JONATHAN, KHANNA, AMARDEEP, COLETTA, MARINA, SAMUEL, SUNIL, ORTIZ, JACOBO, JAMES, MARTIN, WILKES, EMILIE, AITHAL, GURUPRASAD P., GUHA, INDRA N. and SAMI, SARMED S., 2020. Validation of the AASLD recommendations for classification of oesophageal varices in clinical practice LIVER INTERNATIONAL. 40(4), 905-912
• FAN, RONG, PAPATHEODORIDIS, GEORGE, SUN, JIAN, INNES, HAMISH, TOYODA, HIDENORI, XIE, QING, MO, SHUYUAN, SYPSA, VANA, GUHA, INDRA NEIL, KUMADA, TAKASHI, NIU, JUNQI, DALEKOS, GEORGE, YASUDA, SATOSHI, BARNES, ELEANOR, LIAN, JIANQI, SURI, VITHIKA, IDILMAN, RAMAZAN, BARCLAY, STEPHEN T., DOU, XIAOGUANG, BERG, THOMAS, HAYES, PETER C., FLAHERTY, JOHN F., ZHOU, YUANPING, ZHANG, ZHENGANG, BUTI FERRET, MARIA ASUNCION, HUTCHINSON, SHARON J., GUO, YABING, LUIS CALLEJA, JOSE, LIN, LANJIA, ZHAO, LONGFENG, CHEN, YONGPENG, JANSSEN, HARRY L. A., ZHU, CHAONAN, SHI, LEI, TANG, XIAOPING, GAGGAR, ANUJ, WEI, LAI, JIA, JI DONG, IRVING, WILLIAM L., JOHNSON, PHILIP, LAMPERTICO, PIETRO and HOU, JINLIN, 2020. AMAP RISK SCORE PREDICTS HEPATOCELLULAR CARCINOMA DEVELOPMENT IN CHRONIC HEPATITIS PATIENTS: AN INTERNATIONAL COHORT COLLABORATION HEPATOLOGY. 72, 97A-98A
• INNES, HAMISH, BUCH, STEPHAN, HUTCHINSON, SHARON, GUHA, INDRA NEIL, MORLING, JOANNE R., BARNES, ELEANOR, IRVING, WILL, FORREST, EWAN, PEDERGNANA, VINCENT, GOLDBERG, DAVID, ASPINALL, ESTHER, BARCLAY, STEPHAN, HAYES, PETER C., DILLON, JOHN, NISCHALKE, HANS DIETER, LUTZ, PHILIPP, SPENGLER, ULRICH, FISCHER, JANETT, BERG, THOMAS, BROSCH, MARIO, EYER, FLORIAN, DATZ, CHRISTIAN, MUELLER, SEBASTIAN, PECCERELLA, TERESA, DELTENRE, PIERRE, MAROT, ASTRID, SOYKA, MICHAEL, MCQUILLIN, ANDREW, MORGAN, MARSHA Y., HAMPE, JOCHEN and STICKEL, FELIX, 2020. Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1 GASTROENTEROLOGY. 159(4), 1276-+
• GRECIAN, S. M., MCLACHLAN, S., FALLOWFIELD, J. A., GUHA, I. N., MORLING, J. R., WILLIAMSON, R. M., REYNOLDS, R. M., ZAMMITT, N. N., PRICE, J. F., STRACHAN, M. W. J., HAYES, P. C., GLANCY, S. and FRIER, B. M., 2020. Clinical care and other categories posters: Cardiovascular DIABETIC MEDICINE. 37, 21-21
• INNES, H., MORLING, J. R., ASPINALL, E. A., GOLDBERG, D. J., HUTCHINSON, S. J. and GUHA, I. N., 2020. Late diagnosis of chronic liver disease in a community cohort (UK biobank): determinants and impact on subsequent survival PUBLIC HEALTH. 187, 165-171
• NEWSOME, PHILIP N., SASSO, MAGALI, DEEKS, JONATHAN J., PAREDES, ANGELO, BOURSIER, JEROME, CHAN, WAH-KHEONG, YILMAZ, YUSUF, CZERNICHOW, SEBASTIEN, ZHENG, MING-HUA, WONG, VINCENT WAI-SUN, ALLISON, MICHAEL, TSOCHATZIS, EMMANUEL, ANSTEE, QUENTIN M., SHERIDAN, DAVID A., EDDOWES, PETER J., GUHA, INDRA N., COBBOLD, JEREMY F., PARADIS, VALERIE, BEDOSSA, PIERRE, MIETTE, VERONIQUE, FOURNIER-POIZAT, CELINE, SANDRIN, LAURENT and HARRISON, STEPHEN A., 2020. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study LANCET GASTROENTEROLOGY & HEPATOLOGY. 5(4), 362-373
• THIAGARAJAN, PRARTHANA, CHALMERS, JANE, GUHA, INDRA N. and JAMES, MARTIN W., 2020. Detecting chronic liver disease: are liver function tests the solution? BRITISH JOURNAL OF HOSPITAL MEDICINE. 81(2),
• NEIL GUHA, INDRA and PATEL, KEYUR, 2020. Editorial: blood biomarkers for advanced liver fibrosis in non-alcoholic fatty liver disease-not a simple choice? Alimentary pharmacology & therapeutics. 51(1), 179-180
• ATHWAL, VARINDER S., PRITCHETT, JAMES, MARTIN, KATHERINE, LLEWELLYN, JESSICA, SCOTT, JENNIFER, HARVEY, EMMA, ZAITOUN, ABED M., MULLAN, AOIBHEANN F., ZEEF, LEO A. H., FRIEDMAN, SCOTT L., IRVING, WILLIAM L., HANLEY, NEIL A., GUHA, INDRA N. and HANLEY, KAREN PIPER, 2019. SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis (vol 8, 17905, 2018) SCIENTIFIC REPORTS. 9,
• SERRA-BURRIEL, MIQUEL, GRAUPERA, ISABEL, TORAN, PERE, THIELE, MAJA, ROULOT, DOMINIQUE, WONG, VINCENT WAI-SUN, GUHA, INDRA NEIL, FABRELLAS, NURIA, ARSLANOW, ANITA, EXPOSITO, CARMEN, HERNANDEZ, ROSARIO, WONG, GRACE LAI-HUNG, HARMAN, DAVID, MURAD, SARWA DARWISH, KRAG, ALEKSANDER, PERA, GUILLEM, ANGELI, PAOLO, GALLE, PETER, AITHAL, GURUPRASAD P., CABALLERIA, LLORENC, CASTERA, LAURENT, GINES, PERE and LAMMERT, FRANK, 2019. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia JOURNAL OF HEPATOLOGY. 71(6), 1141-1151
• HARRIS, REBECCA, CARD, TIMOTHY R., DELAHOOKE, TOBY, AITHAL, GURUPRASAD P. and GUHA, INDRA N., 2019. Obesity Is the Most Common Risk Factor for Chronic Liver Disease: Results From a Risk Stratification Pathway Using Transient Elastography AMERICAN JOURNAL OF GASTROENTEROLOGY. 114(11), 1744-1752
• ELSHAARAWY, OMAR, MUELLER, JOHANNES, GUHA, INDRA NEIL, CHALMERS, JANE, HARRIS, REBECCA, THIELE, MAJA, MADSEN, BJORN STAEHR, KRAG, ALEKSANDER, STEFANESCU, HORIA, STANCU, OANA, ARDELEAN, ANDREEA and MUELLER, SEBASTIAN, 2019. Spleen to liver stiffness ratio significantly differs between ALD and HCV and predicts disease specific complications JOURNAL OF HEPATOLOGY. 70(1), E640-E640
• EDDOWES, PETER, ALLISON, MICHAEL, TSOCHATZIS, EMMANOUIL, ANSTEE, QUENTIN, SHERIDAN, DAVID, GUHA, INDRA NEIL, COBBOLD, JEREMY, PARADIS, VALERIE, BEDOSSA, PIERRE and NEWSOME, PHILIP, 2019. Effectively reducing screen failure rate in non-alcoholic fatty liver disease clinical trial using the FibroScan-based FAST score combining liver stiffness, controlled attenuation parameter JOURNAL OF HEPATOLOGY. 70(1), E766-E766
• EDDOWES, PETER J., SASSO, MAGALI, ALLISON, MICHAEL, TSOCHATZIS, EMMANOUIL, ANSTEE, QUENTIN M., SHERIDAN, DAVID, GUHA, INDRA N., COBBOLD, JEREMY F., DEEKS, JONATHAN J., PARADIS, VALERIE, BEDOSSA, PIERRE and NEWSOME, PHILIP N., 2019. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease GASTROENTEROLOGY. 156(6), 1717-1730
• HAMMOND, JOHN S., GODTLIEBSEN, FRED, STEIGEN, SONJA, GUHA, I. NEIL, WYATT, JUDY, REVHAUG, ARTHUR, LOBO, DILEEP N. and MORTENSEN, KIM E., 2019. The effects of terlipressin and direct portacaval shunting on liver hemodynamics following 80% hepatectomy in the pig CLINICAL SCIENCE. 133(1), 153-166
• SAMI, SARMED S., LYER, PRASAD G., POPHALI, PRACHI, HALLAND, MAGNUS, DI PIETRO, MASSIMILIANO, ORTIZ-FERNANDEZ-SORDO, JACOBO, WHITE, JONATHAN R., JOHNSON, MICHELE, GUHA, INDRA NEIL, FITZGERALD, REBECCA C. and RAGUNATH, KRISH, 2019. Acceptability, Accuracy, and Safety of Disposable Transnasal Capsule Endoscopy for Barrett's Esophagus Screening CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 17(4), 638-+
• GROVE JI, THIAGARAJAN P, ASTBURY S, HARRIS R, DELAHOOKE T, GUHA IN and AITHAL GP, 2018. Analysis of genotyping for predicting liver injury marker, Procollagen III in persons at risk of non-alcoholic fatty liver disease. Liver International. 38(10), 1832-1838
• HARMAN, D. J., RYDER, S. D., JAMES, M. W., WILKES, E. A., CARD, T. R., AITHAL, G. P. and GUHA, I. N., 2018. Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using transient elastography ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 47(4), 504-515
• KENDALL TJ, DOLMAN GE, DUFF CM, PAISH EC, ZAITOUN A, IRVING W, FALLOWFIELD JA and GUHA IN, 2018. Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease. Histopathology. (In Press.)
• BRADLEY CR, COX EF, SCOTT RA, JAMES MW, KAYE P, AITHAL GP, FRANCIS ST and GUHA IN, 2018. Multi organ assessment of Compensated Cirrhosis Patients using quantitative Magnetic Resonance Imaging. Journal of hepatology. (In Press.)
• ATHWAL, VARINDER S., PRITCHETT, JAMES, MARTIN, KATHERINE, LLEWELLYN, JESSICA, SCOTT, JENNIFER, HARVEY, EMMA, ZAITOUN, ABED M., MULLAN, AOIBHEANN F., ZEEF, LEO A. H., FRIEDMAN, SCOTT L., IRVING, WILLIAM L., HANLEY, NEIL A., GUHA, INDRA N. and HANLEY, KAREN PIPER, 2018. SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis SCIENTIFIC REPORTS. 8,
• DILLON, AUDREY, GALVIN, ZITA, SULTAN, ALYSHAH A., HARMAN, DAVID, GUHA, INDRA N. and STEWART, STEPHEN, 2018. Transient elastography can stratify patients with Child-Pugh A cirrhosis according to risk of early decompensation EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 30(12), 1434-1440
• SAMI, SARMED S., HARMAN, DAVID, RAGUNATH, KRISH, BOHNING, DANKMAR, PARKES, JULIE and GUHA, INDRA NEIL, 2018. Non-invasive tests for the detection of oesophageal varices in compensated cirrhosis: systematic review and meta-analysis UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 6(6), 806-818
• HARRIS, REBECCA, HARMAN, DAVID J, CARD, TIMOTHY R, AITHAL, GURUPRASAD P and GUHA, INDRA NEIL, 2017. Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review.: The lancet. Gastroenterology & hepatology The lancet. Gastroenterology & hepatology. 2, 288-297
• TANAJEWSKI L, HARRIS R, HARMAN DJ, AITHAL GP, CARD TR, GKOUNTOURAS G, BERDUNOV V, GUHA IN and ELLIOTT RA, 2017. Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study. BMJ open. 7(6), e015659
• GINÈS P, GRAUPERA I, LAMMERT F, ANGELI P, CABALLERIA L, KRAG A, GUHA IN, MURAD SD and CASTERA L, 2017. Screening for liver fibrosis in the general population: a call for action. The lancet. Gastroenterology & hepatology. 1(3), 256-260
• HARRIS R, HARMAN DJ, CARD TR, AITHAL GP and GUHA IN, 2017. Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review. The lancet. Gastroenterology & hepatology. 2(4), 288-297
• HARMAN DJ, RYDER SD, JAMES MW, WILKES EA, CARD TR, AITHAL GP and GUHA IN, 2017. Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using transient elastography. Alimentary pharmacology & therapeutics. 47(4), 504-515
• ATHWAL VS, PRITCHETT J, LLEWELLYN J, MARTIN K, CAMACHO E, RAZA SM, PHYTHIAN-ADAMS A, BIRCHALL LJ, MULLAN AF, SU K, PEARMAIN L, DOLMAN G, ZAITOUN AM, FRIEDMAN SL, MACDONALD A, IRVING WL, GUHA IN, HANLEY NA and PIPER HANLEY K, 2017. SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis. EMBO molecular medicine. 9(12), 1696-1710
• GINÈS P, GRAUPERA I, LAMMERT F, ANGELI P, CABALLERIA L, KRAG A, GUHA IN, MURAD SD and CASTERA L, 2017. Screening studies of transient elastography and FibroTest in the general population - Authors' reply. The lancet. Gastroenterology & hepatology. 2(4), 246-247
• NEWSOME PN, FOX R, KING AL, BARTON D, THAN NN, MOORE J, CORBETT C, TOWNSEND S, THOMAS J, GUO K, HULL D, BEARD HA, THOMPSON J, ATKINSON A, BIENEK C, MCGOWAN N, GUHA N, CAMPBELL J, HOLLYMAN D, STOCKEN D, YAP C and FORBES SJ, 2017. Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. The lancet. Gastroenterology & hepatology. 3(1), 25-36
• CHIKHANI M, EVANS DL, BLATCHER AW, JACKSON AP, GUHA IN, AITHAL GP and MOPPETT IK, 2016. The effect of prone positioning with surgical bolsters on liver blood flow in healthy volunteers. Anaesthesia. 71(5), 550-5
• 2016. Non-invasive assessment of Portal Hypertension Using Quantitative Magnetic Resonance Imaging. Journal of hepatology. (In Press.)
• 2016. Visual morphometry and three non-invasive markers in the evaluation of liver fibrosis in chronic liver disease. Scandinavian journal of gastroenterology. 1-9 (In Press.)
• 2016. The Detection of Oesophageal Varices Using a Novel, Disposable, Probe-based Transnasal Endoscope. A Prospective Diagnostic Pilot Study. Liver international : official journal of the International Association for the Study of the Liver. (In Press.)
• HARMAN DJ, RYDER SD, JAMES MW, JELPKE M, OTTEY DS, WILKES EA, CARD TR, AITHAL GP and GUHA IN, 2015. Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography. BMJ open. 5(4), e007516
• SEVRAIN D, DUBREUIL M, DOLMAN GE, ZAITOUN A, IRVING W, GUHA IN, ODIN C and LE GRAND Y, 2015. Evaluation of area-based collagen scoring by nonlinear microscopy in chronic hepatitis C-induced liver fibrosis. Biomedical optics express. 6(4), 1209-18
• HOAD CL, PALANIYAPPAN N, KAYE P, CHERNOVA Y, JAMES MW, COSTIGAN C, AUSTIN A, MARCIANI L, GOWLAND PA, GUHA IN, FRANCIS ST and AITHAL GP, 2015. A study of T1 relaxation time as a measure of liver fibrosis and the influence of confounding histological factors. NMR in biomedicine. 28(6), 706-14
• MORLING JR, FALLOWFIELD JA, WILLIAMSON RM, ROBERTSON CM, GLANCY S, GUHA IN, STRACHAN MWJ and PRICE JF, 2015. γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study. Diabetologia. (In Press.)
• SANDS CJ, GUHA IN, KYRIAKIDES M, WRIGHT M, BECKONERT O, HOLMES E, ROSENBERG WM and COEN M, 2015. Metabolic phenotyping for enhanced mechanistic stratification of chronic hepatitis C-induced liver fibrosis. The American journal of gastroenterology. 110(1), 159-69
• SAMI SS, SUBRAMANIAN V, ORTIZ-FERNÁNDEZ-SORDO J, SAEED A, SINGH S, GUHA IN, IYER PG and RAGUNATH K, 2015. Performance characteristics of unsedated ultrathin video endoscopy in the assessment of the upper GI tract: systematic review and meta-analysis. Gastrointestinal endoscopy. 82(5), 782-92
• MORLING JR, FALLOWFIELD JA, GUHA IN, WILLIAMSON RM, ALI M, GLANCY S, STRACHAN MW and PRICE JF, 2015. Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. QJM : monthly journal of the Association of Physicians. 109(4), 249-56
• WENG SF, KAI J, GUHA IN and QURESHI N, 2015. The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment. Open heart. 2(1), e000272
• MORLING JR, FALLOWFIELD JA, GUHA IN, NEE LD, GLANCY S, WILLIAMSON RM, ROBERTSON CM, STRACHAN MWJ, PRICE JF and EDINBURGH TYPE 2 DIABETES STUDY INVESTIGATORS, 2014. Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study. Journal of hepatology.
• PATEL K, REMLINGER KS, WALKER TG, LEITNER P, LUCAS JE, GARDNER SD, MCHUTCHISON JG, IRVING W and GUHA IN, 2014. Multiplex Protein Analysis to Determine Fibrosis Stage and Progression in Patients With Chronic Hepatitis C. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. (In Press.)
• SCOTT R and GUHA IN, 2014. Non-invasive monitoring of liver fibrosis. British medical bulletin. 112(1), 97-106
• GUHA, I.N., BOKHANDI, S., AHMAD, Z., SHERON, N., COPE, R., MARSHALL, C. and VELDTMAN, G., 2013. Structural and functional uncoupling of liver performance in the Fontan circulation International Journal of Cardiology. 164(1), 77-81
• TANWAR, S., TREMBLING, P.M., GUHA, I.N., PARKES, J., KAYE, P., BURT, A.D., RYDER, S.D., AITHAL, G.P., DAY, C.P. and ROSENBERG, W.M., 2013. Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease Hepatology. 57(1), 103-111
• DOLMAN GE, NIEBOER D, STEYERBERG E, HARRIS S, FERGUSON A, ZAITOUN A, RYDER SD, JAMES MW, AITHAL GP and GUHA IN, 2013. The performance of transient elastography compared to clinical acumen and routine tests – what is the incremental diagnostic value? Liver International. 33(2), 172-9
• JOHNSON G, GUHA IN and DAVIES P, 2013. Were James Bond's drinks shaken because of alcohol induced tremor? BMJ (Clinical research ed.). 347, f7255
• MORLING JR, FALLOWFIELD JA, WILLIAMSON RM, NEE LD, JACKSON AP, GLANCY S, REYNOLDS RM, HAYES PC, GUHA IN, STRACHAN MWJ and PRICE JF, 2013. Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Liver international : official journal of the International Association for the Study of the Liver. (In Press.)
• PARKER MJ, GUHA N, STEDMAN B, HACKING N and WRIGHT M, 2013. Trans-jugular intrahepatic porto-systemic shunt placement for refractory ascites: a 'real-world' UK health economic evaluation. Frontline gastroenterology. 4(3), 182-186
• HARMAN DJ, MCCORRY RB, JACOB RP, LIM TR, O'NEILL R, RYDER SD, JAMES MW, AITHAL GP and GUHA IN, 2012. Economic modelling of early transjugular intrahepatic portosystemic shunt insertion for acute variceal haemorrhage. European journal of gastroenterology & hepatology. (In Press.)
• PARKES J, GUHA IN, HARRIS S, ROSENBERG WM and RODERICK PJ, 2012. Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease. Comparative hepatology. 11(1), 5 (In Press.)
• AITHAL GP, GUHA N, FALLOWFIELD J, CASTERA L and JACKSON AP, 2012. Biomarkers in liver disease: emerging methods and potential applications. International journal of hepatology. 2012, 437508
• PRITCHETT, J., HARVEY, E., ATHWAL, V., BERRY, A., ROWE, C., OAKLEY, F., MOLES, A., MANN, D.A., BOBOLA, N., SHARROCKS, A.D., THOMSON, B.J., ZAITOUN, A.M., IRVING. W.L., GUHA, I.N., HANLEY, N.A. and HANLEY, K.P., 2012. Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans Hepatology. 56(3), 1108-1116
• SNOWDON VK, GUHA N and FALLOWFIELD JA, 2012. Noninvasive evaluation of portal hypertension: emerging tools and techniques. International journal of hepatology. 2012, 691089
• DOLMAN GE, NIEBOER D, STEYERBERG EW, HARRIS S, FERGUSON A, ZAITOUN AM, RYDER SD, JAMES MW, AITHAL GP and GUHA IN, 2012. The performance of transient elastography compared to clinical acumen and routine tests - what is the incremental diagnostic value? Liver international : official journal of the International Association for the Study of the Liver. 33(2), 172-9
• PRITCHETT J, HARVEY E, ATHWAL V, BERRY A, ROWE C, OAKLEY F, MOLES A, MANN DA, BOBOLA N, SHARROCKS AD, THOMSON BJ, ZAITOUN AM, IRVING WL, GUHA IN, HANLEY NA and HANLEY KP, 2012. Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans. Hepatology (Baltimore, Md.). 56(3), 1108-16
• HAMMOND, J S, GUHA, I N, BECKINGHAM, I J and LOBO, D N, 2011. Prediction, prevention and management of postresection liver failure. The British Journal Of Surgery.
• GUHA, INDRA NEIL, MYERS, ROBERT P, PATEL, KEYUR and TALWALKAR, JAYANT A, 2011. Biomarkers of liver fibrosis: What lies beneath the receiver operating characteristic curve? Hepatology (Baltimore, Md.). 54(4), 1454-62
• LE JEUNE IR, GORDON AL, FARRUGIA D, MANWANI R, GUHA IN and JAMES MW, 2011. Safe discharge of patients with low-risk upper gastrointestinal bleeding (ugib): can the use of glasgow-blatchford bleeding score be extended? Acute medicine. 10(4), 176-81
• PARKES, J., GUHA, I.N., RODERICK, P., HARRIS, S., CROSS, R., MANOS, M.M., IRVING, W., ZAITOUN, A., WHEATLEY, M., RYDER, S. and ROSENBERG, W., 2010. Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C Journal of Viral Hepatitis. 18(1), 23-31
• BROWN, MATTHEW R L, JONES, GRAEME, NASH, KATHRYN L, WRIGHT, MARK and GUHA, INDRA NEIL, 2010. Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile rates. World journal of gastroenterology : WJG. 16(42), 5317-23
• KNAPP, S., WARSHOW, U., HEGAZY, D., BRACKENBURY, L., GUHA, I.N., FOWELL, A., LITTLE, A.M., ALEXANDER, G.J., ROSENBERG, W.M.C., CRAMP, M.E. and KHAKOO, S.I., 2010. Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus Hepatology. 51(4), 1168-1175
• GUHA, INDRA NEIL, 2009. Back to the future with noninvasive biomarkers of liver fibrosis. Hepatology (Baltimore, Md.). 49(1), 9-11
• GUHA, I.N., PARKES, J., RODERICK, P., CHATTOPADHYAY, D., CROSS, R., HARRIS, S., KAYE, P., BURT, A.D., RYDER, S.D., AITHAL, G.P., DAY, C.P. and ROSENBERG, W.M., 2008. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers Hepatology: Official Journal of the American Association of the Study of Liver Diseases. 47(2), 455-460
• GUHA, I N and ROSENBERG, W M, 2008. Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities. Clinics in liver disease. 12(4), 883-900, x
• MUDDU, AJAY K, GUHA, INDRA NEIL, ELSHARKAWY, AHMED M and MANN, DEREK A, 2007. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. The international journal of biochemistry & cell biology. 39(4), 695-714
• GUHA, I N and ROSENBERG, W M, 2006. Future use of the Glasgow alcoholic hepatitis score. Gut. 55(1), 135-6
• GUHA, I N, PARKES, J, RODERICK, P R, HARRIS, S and ROSENBERG, W M, 2006. Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease. Gut. 55(11), 1650-60
• PARKES, JULIE, GUHA, INDRA NEIL, RODERICK, PAUL and ROSENBERG, WILLIAM, 2006. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. Journal of hepatology. 44(3), 462-74
• GUHA, I N, STEDMAN, B, IREDALE, J P and SHERON, N, 2005. Case report of an arterioportal fistula, presenting with accelerated decompensation and sepsis, twenty-six years after initial liver biopsy. Hepatology research : the official journal of the Japan Society of Hepatology. 32(4), 252-5
• GUHA, INDRA NEIL and MOORE, KEVIN, 2003. F2-isoprostanes and the liver. Prostaglandins & other lipid mediators. 72(1-2), 73-84